
TRANCE/RANK L/TNFSF11 (159aa) Protein, Mouse(RAW264.7破骨专用)
Tumor necrosis factor ligand superfamily member 11,Osteoclast differentiation factor (ODF),Osteoprotegerin ligand (OPGL),Receptor activator of nuclear factor kappa-B ligand (RANKL),TNF-related activation-induced cytokine (TRANCE),CD254
产品介绍 评论(0)
- 产品介绍
种属
Mouse分子别名
Tumor necrosis factor ligand superfamily member 11; Osteoclast differentiation factor (ODF); Osteoprotegerin ligand (OPGL); Receptor activator of nuclear factor kappa-B ligand (RANKL); TNF-related activation-induced cytokine (TRANCE); CD254Accession
O35235表达序列
Lys158-Asp316, with N-terminal His tag and Flag tag.
表达系统
HEK293分子量
20-25 kDa (Reducing)
纯度
>95% by SDS-PAGE and HPLC.内毒素含量
<0.1EU/μg活性
EC50 < 5ng/ml标签
Flag Tag, His Tag分子标记
Unconjugated性状
Lyophilized Powder缓冲体系
PBS, pH7.4
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件
·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.·1 week, 2 to 8℃ under sterile conditions after reconstitution.·Please avoid repeated freeze-thaw cycles.背景介绍
TNFSF11, also known as Receptor Activator of Nuclear Factor-κB Ligand (RANKL), is a crucial cytokine belonging to the tumor necrosis factor (TNF) superfamily. It is expressed on osteoblasts or T cells and binds to TNFRSF11B (OPG) and TNFRSF11A (RANK) on osteoclasts and precursor cells to regulate their differentiation and proliferation. RANKL plays a vital role in bone remodeling by stimulating osteoclast activity and is essential for maintaining bone homeostasis. In mice, the TNFSF11 gene is located on chromosome 14 and encodes a glycoprotein with an extracellular domain that can be cleaved and released into the bloodstream.
TNFSF11 is a key regulator of osteoclastogenesis and bone resorption. In bone organoid models, TNFSF11 signaling is essential for maintaining the balance between osteoblasts and osteoclasts. By manipulating TNFSF11 levels, researchers can study bone diseases such as osteoporosis and osteopetrosis in a more physiologically relevant context.TNFSF11 is involved in the development and function of secondary lymphoid organs. In immune organoids, TNFSF11 signaling can influence the formation of lymphoid structures and the activation of immune cells. This makes it a valuable target for studying immune responses and developing new therapeutic strategies for autoimmune diseases.文献引用
Nat Rev Drug Discov. 2024 Dec;23(12):939-961.







评论(0)